NAD+ Infusion

An intravenous NAD+ infusion delivering nicotinamide adenine dinucleotide directly into the bloodstream for cellular energy restoration, mitochondrial support, and anti-ageing benefits at one of Poland's most competitive price points.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy production in the mitochondria, DNA repair, sirtuin-mediated gene regulation, and neurotransmitter synthesis. Natural NAD+ levels decline significantly with age — research suggests levels may halve between ages 40 and 60 — contributing to reduced cellular function, lower energy, impaired DNA repair, and accelerated ageing processes. Intravenous NAD+ therapy bypasses the severe bioavailability limitations of oral supplementation, where 80-90% of the active molecule is degraded during first-pass metabolism in the gut and liver. IV delivery achieves plasma concentrations that oral NMN or NR precursors cannot match, providing direct substrate for the NAD+-dependent enzymes that drive cellular repair and longevity pathways. At 1,100 PLN (approximately €255 at current exchange rates), RC Clinic's NAD+ infusion represents exceptional value compared to Western European pricing, where equivalent treatments typically cost €300-500. This price differential makes Warsaw an attractive destination for medical tourists seeking NAD+ therapy as part of a longevity or biohacking protocol. The infusion is administered under medical supervision following an initial consultation (250 PLN, waived when the infusion is performed the same day). The slow drip rate minimises the temporary flushing and nausea that can occur when NAD+ enters the bloodstream too quickly. Most clients report increased mental clarity and energy within hours, with peak effects developing over 1 to 3 days.